Caralluma tuberculata N. E. Brown is herb distributed in dry regions of the world. The succulent stem of the plant is widely used to treat several ailments including diabetes, rheumatism, leprosy, peptic ulcer, inflammation, jaundice, dysentery, constipation, stomach pain, hepatitis B and C. Phytochemical investigation of plant discovered the presence of flavone glycosides, pregnane glycosides and lupeol because of which it possess antioxidant activity. The plant is documented to possess beneficial effects as antihyperglycemic, antibacterial, antifungal, antinociceptive and antiproliferative activitie. The effect of this plant may delay the development of diseases and provide a rich source for antioxidants that are known to prevent different diseased states. Objective of current study is to review pharmacological and ethno botanical properties of Caralluma tuberculata.
Androstan glycoside light greenishwhite, amorphous powder Anti-proliferative effects of C. tuberculata were studied using MTT assay and results confirmed the worth in the treatment of cancer. A series of eight dilutions of C. tuberculata crude extract (10 -500 µg ml -1 ) were used to determine the concentrationdependent, anti-proliferative effect on three cancer cell lines (MCF-7, MDA-MB-468, Caco-2). The data indicated significant concentration-dependent growth inhibition of the malignant cells after 24 hours with an apparent IC50 value of about 100 µg/ml with the neutral red uptake (NRU) assay. Similar results were obtained with the MTT assay, where the IC50 value was about 200µg ml Toxicity of Caralluma tuberculata.
Phytotoxicity.
Evaluation of phytotoxic activity of C. tuberculata stem extracts against Lemna minor at concentration of 1000 μg ml -1 was 75% displayed that this plant possess strong phytotoxic activity and hence could be further exploited for use in natural herbicide formulations. C. tuberculata methanol extract showed the inhibition of growth / germination of roots and shoots of rice (Oryza sitiva) [22] . The plant was evidenced as plant growth inhibitor.
Acute and Chronic Toxicity.
Evaluation of safety profile of C. tuberculata by gross behavioural, acute and chronic toxicity study of ethyl acetate fraction of ethanol extract in Swiss albino mice support the safe folklore use of this plant as a drug as it did not affect the biochemical and hematological parameters and also has no effect on the growth of vital body organs [25] . Cytotoxicty. C. tuberculata methanol extract was reported to possess excellent cytotoxic activity at 1000 µg ml -1 of which is 100% activity; at the 100 µg ml -1 concentration the plant extract also shows 100% cytotoxic activity while at 10µg ml -1 it shows 70% cytotoxic activity [17] . Conservation status of C. tuberculata. C. tuberculata is documented as a highly threatened species [26] ; it is going towards decline because of over and unscientific collection. These valuable medicinal plants species are at the verge of extinction if are not used sustainably [13] . Suitable conservation strategies must be made to conserve those plants that have immense medicinal value. Caralluma tuberculata need to be conserved by educating the people to use them in a sustainable way. If such measurements are not adopted in due time, these valuable plants will be no more part of world. Conclusions C. tuberculata is an important source of many pharmacologically and medicinally important chemicals responsible for different biological activities. In the present review an attempt has been made to present C. tuberculata as medicinal plant by presenting its botanical, phytochemical, ethno botanical, and pharmacological information which will be supportive for future drug discovery and may be useful to the health professionals, scientists and scholars working in the field of pharmacology and therapeutics. Caralluma fimbriata in the treatment of obesity 12th annual congress on anti-
